Search Results

There are 22057 results for: content related to: Optimizing docetaxel chemotherapy in patients with cancer of the gastric and gastroesophageal junction

  1. Chemotherapy for advanced gastric cancer

    Intervention Review

    The Cochrane Library

    Anna Dorothea Wagner, Nicholas LX Syn, Markus Moehler, Wilfried Grothe, Wei Peng Yong, Bee-Choo Tai, Jingshan Ho and Susanne Unverzagt

    Published Online : 29 AUG 2017, DOI: 10.1002/14651858.CD004064.pub4

  2. You have full text access to this OnlineOpen article
    Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose

    Cancer Science

    Volume 106, Issue 5, May 2015, Pages: 497–504, Hirotsugu Kenmotsu and Yusuke Tanigawara

    Version of Record online : 25 MAR 2015, DOI: 10.1111/cas.12647

  3. Docetaxel Nanotechnology in Anticancer Therapy

    ChemMedChem

    Volume 7, Issue 6, June 2012, Pages: 952–972, Pengxiang Zhao and Didier Astruc

    Version of Record online : 19 APR 2012, DOI: 10.1002/cmdc.201200052

  4. You have free access to this content
    Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer

    British Journal of Clinical Pharmacology

    Volume 69, Issue 5, May 2010, Pages: 465–474, Stijn L. W. Koolen, Roos L. Oostendorp, Jos H. Beijnen, Jan H. M. Schellens and Alwin D. R. Huitema

    Version of Record online : 28 JAN 2010, DOI: 10.1111/j.1365-2125.2010.03621.x

  5. Co-administration of piperine and docetaxel results in improved anti-tumor efficacy via inhibition of CYP3A4 activity

    The Prostate

    Volume 72, Issue 6, 1 May 2012, Pages: 661–667, Peter Makhov, Konstantin Golovine, Daniel Canter, Alexander Kutikov, Jay Simhan, Melany M. Corlew, Robert G. Uzzo and Vladimir M. Kolenko

    Version of Record online : 27 JUL 2011, DOI: 10.1002/pros.21469

  6. Rh2 or its aglycone aPPD in combination with docetaxel for treatment of prostate cancer

    The Prostate

    Volume 70, Issue 13, 15 September 2010, Pages: 1437–1447, Alain G. Musende, Andy Eberding, William Jia, Euan Ramsay, Marcel B. Bally and Emma Tomlinson Guns

    Version of Record online : 28 APR 2010, DOI: 10.1002/pros.21179

  7. Comparison of preoperative chemotherapy using docetaxel, cisplatin and fluorouracil with cisplatin and fluorouracil in patients with advanced carcinoma of the thoracic esophagus

    Diseases of the Esophagus

    Volume 28, Issue 2, February/March 2015, Pages: 180–187, T. Ui, H. Fujii, Y. Hosoya, M. Nagase, M. N. Mieno, M. Mori, T. Zuiki, S. Saito, K. Kurashina, H. Haruta, S. Matsumoto, T. Niki, A. Lefor and Y. Yasuda

    Version of Record online : 17 FEB 2014, DOI: 10.1111/dote.12187

  8. You have free access to this content
    Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre study

    BJU International

    Volume 106, Issue 7, October 2010, Pages: 974–978, Jean-Christophe Eymard, Stéphane Oudard, Gwenaelle Gravis, Jean-Marc Ferrero, Christine Theodore, Florence Joly, Frank Priou, Ivan Krakowski, Alain Zannetti, Laurence Thill and Philippe Beuzeboc

    Version of Record online : 14 SEP 2010, DOI: 10.1111/j.1464-410X.2010.09296.x

  9. Docetaxel increases antitumor efficacy of oncolytic prostate-restricted replicative adenovirus by enhancing cell killing and virus distribution

    The Journal of Gene Medicine

    Volume 12, Issue 6, June 2010, Pages: 516–527, Xiong Li, Youhong Liu, Yong Tang, Phipps Roger, Meei-Huey Jeng and Chinghai Kao

    Version of Record online : 17 MAY 2010, DOI: 10.1002/jgm.1462

  10. You have free access to this content
    Ritonavir inhibits intratumoral docetaxel metabolism and enhances docetaxel antitumor activity in an immunocompetent mouse breast cancer model

    International Journal of Cancer

    Volume 138, Issue 3, 1 February 2016, Pages: 758–769, Jeroen J.M.A. Hendrikx, Jurjen S. Lagas, Ji-Ying Song, Hilde Rosing, Jan H.M. Schellens, Jos H. Beijnen, Sven Rottenberg and Alfred H. Schinkel

    Version of Record online : 21 SEP 2015, DOI: 10.1002/ijc.29812

  11. You have free access to this content
    Docetaxel rechallenge after an initial good response in patients with metastatic castration-resistant prostate cancer

    BJU International

    Volume 115, Issue 5, May 2015, Pages: 744–752, Stéphane Oudard, Gero Kramer, Orazio Caffo, Lorraine Creppy, Yohan Loriot, Steinbjoern Hansen, Mats Holmberg, Frederic Rolland, Jean-Pascal Machiels and Michael Krainer

    Version of Record online : 29 DEC 2014, DOI: 10.1111/bju.12845

  12. You have free access to this content
    Rational indication for docetaxel rechallenge in metastatic castration-resistant prostate cancer

    BJU International

    Volume 110, Issue 11b, December 2012, Pages: E635–E640, Matthias M. Heck, Mark Thalgott, Margitta Retz, Petra Wolf, Tobias Maurer, Roman Nawroth, Georgios Hatzichristodoulou, Jürgen E. Gschwend and Hubert Kübler

    Version of Record online : 13 AUG 2012, DOI: 10.1111/j.1464-410X.2012.11364.x

  13. Functional p53 determines docetaxel sensitivity in prostate cancer cells

    The Prostate

    Volume 73, Issue 4, March 2013, Pages: 418–427, Chengfei Liu, Yezi Zhu, Wei Lou, Nagalakshmi Nadiminty, Xinbin Chen, Qinghua Zhou, Xu Bao Shi, Ralph W. deVere White and Allen C. Gao

    Version of Record online : 19 SEP 2012, DOI: 10.1002/pros.22583

  14. Preparation and pharmacokinetics of docetaxel based on nanostructured lipid carriers

    Journal of Pharmacy and Pharmacology

    Volume 61, Issue 11, November 2009, Pages: 1485–1492, Xiang Li, Dongkai Wang, Jing Zhang and Weisan Pan

    Version of Record online : 8 JAN 2010, DOI: 10.1211/jpp.61.11.0007

  15. Quantification of docetaxel and its metabolites in human plasma by liquid chromatography/tandem mass spectrometry

    Rapid Communications in Mass Spectrometry

    Volume 27, Issue 17, 15 September 2013, Pages: 1925–1934, J. J. M. A. Hendrikx, A. C. Dubbelman, H. Rosing, A. H. Schinkel, J. H. M. Schellens and J. H. Beijnen

    Version of Record online : 19 JUL 2013, DOI: 10.1002/rcm.6654

  16. You have free access to this content
    The combination of alisertib, an investigational Aurora kinase A inhibitor, and docetaxel promotes cell death and reduces tumor growth in preclinical cell models of upper gastrointestinal adenocarcinomas

    Cancer

    Volume 119, Issue 4, 15 February 2013, Pages: 904–914, Vikas Sehdev, Ahmed Katsha, Jeffrey Ecsedy, Alexander Zaika, Abbes Belkhiri and Wael El-Rifai

    Version of Record online : 12 SEP 2012, DOI: 10.1002/cncr.27801

  17. Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo

    The Prostate

    Volume 72, Issue 8, 1 June 2012, Pages: 856–867, J.Y. Henry, L. Lu, M. Adams, B. Meyer, J.B. Bartlett, Prof. A.G. Dalgleish and C. Galustian

    Version of Record online : 3 OCT 2011, DOI: 10.1002/pros.21488

  18. From Mouse to Man: Predictions of Human Pharmacokinetics of Orally Administered Docetaxel From Preclinical Studies

    The Journal of Clinical Pharmacology

    Volume 52, Issue 3, March 2012, Pages: 370–380, Mr S. L. W. Koolen, Dr R. A. B. van Waterschoot, Dr O. van Tellingen, Dr A. H. Schinkel, Dr J. H. Beijnen, Dr J. H. M. Schellens and Dr A. D. R. Huitema

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010397051

  19. Abstract

    Diseases of the Esophagus

    Volume 27, Issue S1, September 2014, Pages: 3A–168A,

    Version of Record online : 19 SEP 2014, DOI: 10.1111/dote.12287

  20. MicroRNA-181a promotes docetaxel resistance in prostate cancer cells

    The Prostate

    Volume 77, Issue 9, June 15, 2017, Pages: 1020–1028, Cameron M. Armstrong, Chengfei Liu, Wei Lou, Alan P. Lombard, Christopher P. Evans and Allen C. Gao

    Version of Record online : 8 MAY 2017, DOI: 10.1002/pros.23358